Skip to main content
Premium Trial:

Request an Annual Quote

Applying It

Publisher Elsevier has announced that it is launching a new open-access journal called Applied and Translational Genomics. "Applied and Translational Genomics has a broad scope and provides a home for high-quality research in the areas that sometimes get caught in between basic research and clinical trials," says Bart Wacek, executive publisher of life sciences at Elsevier, in a statement.

A few papers have already been posted online to the journal at ScienceDirect, including one from the Cyprus Institute of Neurology and Genetics' Philippos Patsalis. Patsalis describes a non-invasive approach, based on MeDIP real-time qPCR, for prenatal diagnosis of Down syndrome.

And in an editorial, the journal's editor-in-chief, Cardiff University's Dhavendra Kumar, lists areas that are within the scope of the new journal. "The journal shall endeavor to publish material related to industrial, agricultural, environmental, medicine and health, and social and ethical applications of genome science and technologies," Kumar writes.